| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Gain from change in fair value of warrant liabilities | 0 | 0 | ||
| Net income (loss) | -10,807 | -44,224 | ||
| Adjustment for change in fair value of warrant liabilities | 0 | 0 | ||
| Adjusted numerator, diluted | -10,807 | -44,224 | ||
| Net income (loss) per share, basic (in dollars per share) | -0.22 | -0.92 | ||
| Net loss per share, diluted (in dollars per share) | -0.22 | -0.92 | ||
| Shares used in computing net income (loss) per share, basic (in shares) | 48,308,000 | 48,308,000 | ||
| Shares used in computing net loss per share, diluted (in shares) | 48,308,000 | 48,308,000 | ||
CASSAVA SCIENCES INC (SAVA)
CASSAVA SCIENCES INC (SAVA)